NuCana plc (NCNA) stock
NCNANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.83−0.06 (-6.43%)
Close on Nov 18, 2026Market cap $3.47MP/E –Yield –
NuCana shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
NuCana's shares outstanding was 20.93B at Jun 30, 2026. For fiscal 2025 it was 11.23B, up 15038.7% from the year before. Over ten years it grew 84.9% a year on average. The highest annual figure on record is 11.23B in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 11.23B | +15038.7% |
| FY2024 | Dec 31, 2024 | 74M | +41.1% |
| FY2023 | Dec 31, 2023 | 53M | +0.6% |
| FY2022 | Dec 31, 2022 | 52M | +0.4% |
| FY2021 | Dec 31, 2021 | 52M | +37.4% |
| FY2020 | Dec 31, 2020 | 38M | +17.2% |
| FY2019 | Dec 31, 2019 | 32M | +1.1% |
| FY2018 | Dec 31, 2018 | 32M | +22.6% |
| FY2017 | Dec 31, 2017 | 26M | +8.1% |
| FY2016 | Dec 31, 2016 | 24M | +0.0% |
| FY2015 | Dec 31, 2015 | 24M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 20.93B | +39995.3% |
| Q2 FY2025 | Jun 30, 2025 | 5.17B | +9814.1% |
| Q2 FY2024 | Jun 30, 2024 | 57M | +8.6% |
| Q2 FY2023 | Jun 30, 2023 | 52M | +0.4% |
| Q2 FY2022 | Jun 30, 2022 | 52M | +1.1% |
| Q4 FY2021 | Dec 31, 2021 | 52M | +1.8% |
| Q3 FY2021 | Sep 30, 2021 | 52M | +48.6% |
| Q2 FY2021 | Jun 30, 2021 | 52M | +59.7% |
| Q1 FY2021 | Mar 31, 2021 | 52M | +59.0% |
| Q4 FY2020 | Dec 31, 2020 | 51M | +57.9% |
| Q3 FY2020 | Sep 30, 2020 | 35M | +8.4% |
| Q2 FY2020 | Jun 30, 2020 | 33M | +1.3% |
| Q1 FY2020 | Mar 31, 2020 | 32M | +0.8% |
| Q4 FY2019 | Dec 31, 2019 | 32M | +0.8% |
| Q3 FY2019 | Sep 30, 2019 | 32M | +1.0% |
| Q2 FY2019 | Jun 30, 2019 | 32M | +1.3% |
| Q1 FY2019 | Mar 31, 2019 | 32M | +1.3% |
| Q4 FY2018 | Dec 31, 2018 | 32M | +132988.1% |
| Q3 FY2018 | Sep 30, 2018 | 32M | +132445.0% |
| Q2 FY2018 | Jun 30, 2018 | 32M | – |
| Q1 FY2018 | Mar 31, 2018 | 32M | – |
| Q3 FY2017 | Sep 30, 2017 | 0M | – |
| Q2 FY2017 | Jun 30, 2017 | 0M | – |
See a number that looks wrong?